Foghorn Therapeutics Inc
(FHTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 22,602 | 34,155 | 19,228 | 1,319 | 430 |
| Gross Profit | 22,602 | 34,155 | 19,228 | 1,319 | 430 |
| Operating Expenses | 125,285 | 142,061 | 136,365 | 102,053 | 68,961 |
| Operating Income | -102,683 | -107,906 | -117,137 | -100,734 | -68,531 |
| Interest Expense | 0 | 0 | 0 | 1,906 | 979 |
| Other Income | 16,063 | 13,706 | 8,255 | 1,320 | 710 |
| Pre-tax Income | -86,620 | -94,200 | -108,882 | -101,320 | -68,800 |
| Income Tax | 0 | 4,226 | N/A | N/A | N/A |
| Net Income Continuous | -86,620 | -98,426 | -108,882 | -101,320 | -68,800 |
| Net Income | $-86,620 | $-98,426 | $-108,882 | $-101,320 | $-68,800 |
| EPS Basic Total Ops | -1.58 | -2.34 | -2.62 | -2.73 | -6.23 |
| EPS Basic Continuous Ops | -1.58 | -2.34 | -2.62 | -2.73 | -6.23 |
| EPS Diluted Total Ops | -1.58 | -2.34 | -2.62 | -2.73 | -6.23 |
| EPS Diluted Continuous Ops | -1.58 | -2.34 | -2.62 | -2.73 | -6.23 |
| EPS Diluted Before Non-Recurring Items | -1.58 | -2.34 | -2.62 | -2.73 | -6.23 |
| EBITDA(a) | $-104,176 | $-107,106 | $-115,111 | $-97,328 | $-67,205 |